{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-091769","form_type":"8-K","ticker":"HRTX","cik":"0000818033","company_name":"HERON THERAPEUTICS, INC. /DE/","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.969055+00:00","generated_at":"2026-05-31T12:47:02.199426+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Heron Therapeutics Q2 net product sales $36.0M; narrows 2024 guidance","bullets":["Q2 net product sales $36.0M, up from $31.8M YoY; acute care franchise $6.8M, oncology $29.2M.","ZYNRELEF VAN PDUFA goal date set for September 23, 2024; launch expected before year-end.","2024 guidance narrowed: adjusted operating expenses $107-111M (prev $108-116M), adjusted EBITDA ($10) to $3M (prev ($22) to $3M).","ZYNRELEF included in proposed 2025 NOPAIN Act as a qualifying product effective April 1, 2025.","CrossLink partnership expanding; 561 sales representatives trained to promote ZYNRELEF to orthopedic surgeons."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-091769","json":"https://secwatch.observer/filing/0000950170-24-091769.json","markdown":"https://secwatch.observer/filing/0000950170-24-091769.md","text":"https://secwatch.observer/filing/0000950170-24-091769.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818033/000095017024091769/0000950170-24-091769-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818033/000095017024091769/hrtx-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:47:02.199426+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}